DOCSLIB.ORG

Front Matter (PDF)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Front Matter (PDF) CancerResearch AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH July 1, 1996 Volume 56 •¿Number 13 PP. 2881-3163 ISSN 0008-5472 •¿CNREA 8 The Definitive Reference for Your Lab and Library >^~^ Encyclopedia of CancerEditor-in-Chief JOSEPH R. BERTINO Sloan-Kettering Institute for Cancer Research. Memorial Sloan-Kettering Cancer Center, New York. New York, and Past President of the American Association for Cancer Research From the Prepublication Reviews PraisefortheArticle"AtaxiaTelangiectasiaSyndrome" PraisefortheArticle"Hypertnermia" TOPICSCOVERED "Covers every aspect of the disease from its clinical "The manuscript is well written by two authors very features to its underlying cellular and molecular knowledgeable in the subject, and the materia/ covered mechanisms in a concise and well-organized is broad enough and in depth enough for the purpose •¿Antisense,Ribosomes stated in the publishers descriptor." fashion...The material presented was complete and up-to-date." •¿BiologyofCancer —¿MICHAELBORRELLI,William Beaumont Hospital —¿MICHAEL B.KASTAN. Johns Hopkins Hospital Royal Oak. Michigan Johns Hopkins University. Baltimore. Maryland PraisefortheArticle"RadiotherapyandConcomitantChemotherapy" Praise for the Article "Interactions Between Drugs and Regulators "This is a comprehensive review of the subject, dealing in the Treatment of Leukemia" with rationale, toxicity, and applications of combined "Excellent review and discussion by the author of an chemoradiotherapy. The coverage of various tumor types Chemotherapy important area." is particularly broad and well organized." GeneTherapy —¿ERICJ. FELDMAN. New York Medical College. Valhalla —¿PHILIPC. HOFFMAN. University of Chicago Medical Center, Illinois Praise for the Article "Differentiation & Cancer" Oncogenes "This is a clearly written article." Praisefor theArticle"RASGeneAlterationsin HumanLungCancer" "Excellent/" —¿GARYS.STEIN. University of Massachusetts Radiation Medical Center, Worcester —¿RALPHHRUBAN.Johns Hopkins Medical Center Carcinogenesis Baltimore, Maryland I he Encyclopedia of Cancer is the authoritative reference source for the rapidly growing field of cancer ViralCarcinogenesisresearch and all associated fields.This three-volume encyclopedia contains more than 150 expressly written articles exploring the causes, potential cures, and preventive measures of cancer. With the recent attention BiologicalTreatment focused on breast cancer, cancer research has once again been thrust to the forefront of scientific investi gation and interest. Epidemiology The Editor and Editorial Board have successfully compiled a comprehensive source of information that is beneficial to undergraduates, graduate students, and seasoned professionals, as well as to the lay person Chemoprevention interested in the causes and cures of cancer that may be affecting a loved one.The Encyclopedia is easy to read, easy to use, and meticulously covers all of the "hot" topics in cancer research.This three-volume set will DrugResistance be a valuable addition to libraries, universities, medical and nursing schools, biotechnology companies, and research institutions. InvasionandSpread ofCancer KEY FEATURES •¿Three-volume set containing more than ISO articles •¿Approximately 1600 pages in a large 8 I/2" x I I" format TumorSuppressor Genes •¿Comprehensive table of contents and subject index in each volume •¿Each article includes a table of contents, glossary, defining paragraph, and extended bibliography RadiationTherapy •¿Appropriate for an international mix of researchers, scientists, and clincians working in the various fields of cancer Three-Volume Set Genetics October1996.c. 1600pp..$475.00(lentetivel/ISBN:0-12-093230-X •¿"-"•"•»-ghDecember31.1996. Order from your local bookseller or directly from: ACADEMICPRESS,INC. IntheU.S.andCanada OrderFulfillmentDept.DM27103 KJV . CALLTOLLFFREE:1-800-321 -5068 6277SeaHarborDrive,Orlando,FL32887 : FAX:FAX 1-800-11-800-874-6418 24-28OvalRoad,LondonNW17DX,U.K. •¿i E-MAIL:[email protected]<s AcademicPress i In Europe.CALL:0181-300-3322 http://www.apnet.com/ Prices subject to change without notice. ©1996 by Academic Press, Inc. All Rights Reserved, LK/KJ/SLR/LBS-19076 CELL SIGNALINGAND CANCERTREATMENT AnAmericanAssociationforCancerResearchSpecialConference in Collaborationwith AustrianCancerSociety,BritishAssociationforCancerResearch, GermanCancerSocietyandtheAustrianBiochemicalSociety February23-28,1997 Interalpen-HotelTyrol Telfs-Buchen, Austria CONFERENCE CHAIRPERSONS HansH.Grunicke/ Innsbruck,Austria GarthPowis/ Tucson,USA PaulWorkman/ Macclesfield,England PROGRAMCOMMITTEE SaraA.Courtneidge/ RedwoodCity,USA PeterHilgard/ Frankfurt,Germany SylvieGisselbrecht/ Paris,France AlexMatter/ Basel,Switzerland BerndGroner/ Freiburg,Germany FrankP.McCormick/ Richmond,USA AdrianL.Harris/ Oxford,England LaurentMeijer/ Roscoff,France PeterA.Herrlich/ Karlsruhe,Germany MichaelJ. Morin/ Groton,USA AxelUllrich/ Munich,Germany SCIENTIFIC PROGRAM KeynoteAddress ProgrammedCellDeath:Rolein Oncogenesis PaulWorkman / Macclesfield,England andTumorTherapy GerardI. Evan/ London,England GrowthFactorAntagonistsand Growth CarolineDive/ Manchester,England FactorReceptorBlockers DouglasR.Green/ LaJolla,USA EnriqueRozengurt/ London,England DonaldW. Nicholson/ Pointe-Claire-Dorval,Quebec,Canada NancyE.Hynes/ Basel,Switzerland BerndGroner/ Freiburg,Germany Invasionand Metastasis NicholasLydon/ Basel,Switzerland MaxM.Burger/ Basel,Switzerland LouisF.Reichardt/ SanFrancisco,USA ReceptorandPostReceptorSignaling: John G. Collard / Amsterdam,The Netherlands MechanismsandTargetsinCancer HelmutPonta/ Karlsruhe,Germany Chemotherapy SaraA.Courtneidge/ RedwoodCity,USA Angiogenesis FrankP.McCormick/ Richmond,USA AdrianL Harris/ Oxford,England NicholasK. Tonks/ ColdSpringHarbor,USA Karl K. Alitalo/ Helsinki,Finland GarthPowis/ Tucson,USA IsaiahJ. Fidler/ Houston,USA Ulf R. Rapp/ Würzburg,Germany Alan K. Hall/ London,England Applicants are encouraged to submit abstracts Axel Ullrich/ Munich,Germany for poster presentation. Application deadline: November 1, 1996 Cell Cycleand Cancer LaurentMeijer/ Roscoff,France ChristianBrechet/ Paris,France InformationandApplicationForms RolfMüller/ Marburg,Germany American Association for Cancer Research J. WadeHarper/ Houston,USA Public Ledger Building, Suite 816 150 South Independence Mall West CytokineSignaling Philadelphia, PA 19106-3483 SylvieGisselbrecht/ Paris,France 215-440-9300 215-440-9313 (FAX) AtsushiMiyayima/ Tokyo,Japan E-mail: [email protected] IanM.Kerr/ London,England GennaroCiliberto/ Rome,Italy Associate Professor/Professor AMERICAN ASSOCIATION FOR Departments of Medicine and Immunology CANCER RESEARCH The American Association for Cancer Research The myeloma program at the University of Arkansas for (AACR) is a professional society of over 11,000 Medical Sciences' Arkansas Cancer Research Center invites scientists and physicians involved in all aspects of applications for a senior immunologist position in the basic, clinical, and translational cancer research. Departments of Medicine and Immunology. Applicants Members of the AACR enjoy should have a strong record in basic immunology, preferably •¿subscriptions to Cancer Research, Cell Growth & transplantation immunology and must demonstrate ability to Differentiation (CG&D), Cancer Epidemiology, interact with clinical scientists in performing translational Biomarkers & Prevention, and Clinical Cancer research that will introduce novel immunotherapeutic Research at reduced member rates approaches to cancer into the clinic. In its 3rd year of NIH •¿reduced registration rates at the AACR Annual funding, the myeloma program consists of a dozen basic and Meeting, Special Conferences, and International clinical scientists dedicated to understanding and treating Meetings multiple myeloma and occupies 12,500 ft2 of laboratory •¿Employment Register, Directory of Members, space. More than 300 patients with myeloma are treated public education activities, and many other benefits annually. Expertise is available in myeloma biology, gene therapy, myeloma-related bone disease, cellular and Special programs to provide enhanced career devel molecular genetics, and transplantation. The successful opment opportunities for minority scientists include candidate will have a history of peer-reviewed funding with •¿Session on Career Development at Annual experience in the basic science/clinical interface of Meeting immunologie research and immunotherapy. Outstanding •¿Mentorship Program salary, full university benefits, and start-up support are •¿Travel Awards to Scientific Meetings available, depending on the candidate's past record of American Association for Cancer Research productivity and academic seniority. Send CV to: Bart Public Ledger Building, Suite 816 Barlogie, MD, PhD; Director, Division of Hematology/ 150 S. Independence Mall West Philadelphia, PA 19106-3483 Oncology; Director of Research and Deputy Director, ACRC; Telephone: (215) 440-9300 University of Arkansas for Medical Sciences; 4301 W. FAX: (215) 440-9313 / E-Mail: [email protected] Markham, Slot 508; Little Rock, AR 72205; FAX: 501-686- 6442. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER World Health Organization Lyon - France FELLOWSHIPS FOR Thisspacecontributed RESEARCH TRAINING IN CANCER asa publicservice. 1997-1998 Applications for trainine fellowships in 1997-1998 are invited from junior scientists wishing lo be tnined in those aspects of cancer research related to the Agency's
Load more

Recommended publications
  • Special Edition Inside
    A Publication by The American Society for the Pharmacology and Experimental Therapeutics Pharmacologist Inside: Feature articles from 2014-2015 Special Edition VISIT THE ASPET CAREER CENTER TODAY! WWW.ASPET.ORG/CAREERCENTER/ 4 5 12 21 30 41 WHAT YOU NEED: ASPET’S CAREER CENTER HAS IT 52 Jobseekers: Employers: No registration fee Searchable résumé database Advanced search options Hassle-free posting; online account management tools 61 Sign up for automatic email notifi cations of new jobs that Reach ASPET’s Twitter followers (over 1,000), match your criteria LinkedIn Members (over 2,000), and email subscribers (over 4,000) Free & confi dential résumé posting 71 Post to just ASPET or to entire NHCN network Access to jobs posted on the National Healthcare Career Network (NHCN) Sign up for automatic email notifications of new résumés that match your criteria Career management resources including career tips, coaching, résumé writing, online profi le development, Job activity tracking and much more ASPET is committed to your success: The ASPET Career Center is the best resource for matching job seekers and employers in the pharmacology and related health science fi elds. Our vast range of resources and tools will help you look for jobs, fi nd great employees, and proactively manage 9650 Rockville Pike, Bethesda, MD 20814-3995 your career goals. Main Office: 301.634.7060 www.aspet.org ASPET Career Center Full Page Ad 2015 Updated.indd 1 1/15/2016 3:18:16 PM The Pharmacologist is published and distributed by the American Society for Pharmacology and Experimental Therapeutics. THE PHARMACOLOGIST VISIT THE ASPET CAREER CENTER TODAY! PRODUCTION TEAM Rich Dodenhoff Catherine Fry, PhD WWW.ASPET.ORG/CAREERCENTER/ Judith A.
    [Show full text]
  • John Burchenal Oral History Interview
    Joseph Burchenal Interview, January 26, 2001 1 National Cancer Institute Oral History Interview Project Interview with Joseph Burchenal Conducted on January 26, 2001 by Peggy Dillon Darien, Connecticut PD: Good morning. This is Peggy Dillon of History Associates Incorporated. I am speaking with Dr. Joseph Burchenal for the NCI oral history interview series. We are at his home in Darien, Connecticut. Today is January 26, 2001. JB: Good morning. PD: I would like to talk with you today about your work in cancer chemotherapy in general and also your involvement with the National Cancer Institute in particular. Before we get into your career overall and NCI, I'd like to ask you about your background. If you could just tell me a little bit about your upbringing and education . I understand that you were interested in chemistry from a very early age. JB: I was born in Milford, Delaware, but I lived in Wilmington, Delaware, for the first part of my life. My mother died when I was three, in childbirth. So I lived with my father in Wilmington. He was a lawyer. I went to school at Tower Hill School. The majority of my friends in the school had fathers or mothers–fathers mainly–who worked for Dupont. They were very likely to, so that there was a lot of interest in chemistry there. In fact, it was the same way on the street where we lived, where the fathers were mostly chemists. But my interest in chemistry, I guess, started when I was eight years old and I had a cousin who was eleven who was given a Chemcraft set and he used to show us all of the interesting things that he could do with it.
    [Show full text]
  • Physiologist President Earl H
    THE AMERICAN PHYSIOLOGICAL SOCIETY Founded in 1887 for the purpose of promoting the increase of The physiological knowledge and its utilization. OFFICERS Physiologist President Earl H. Wood, Mayo Med. Sch., Rochester, MN President-Elect Francis J . Haddy, Uniformed Services Univ. of Hlth. Sci., Volume 24, No. 2, April 1981 Bethesda, MD Past President TABLE OF CONTENTS Ernst Knobil, Univ. of Pittsburgh HISTORICAL ARTICLES Council George H. Whipple --- Horace W. Davenport. Earl H. Wood, Francis J. Haddy, Ernst Knobil, Jack L. Kostyo, Centennial Celebration 5 S. McD. McCann, Paul C. Johnson, Leon Farhi SOCIETY AFFAIRS Executive Secretary-Treasurer Notes from Capitol Hill. 6 Orr E. Reynolds, 9650 Rockville Pike, Bethesda, Maryland Legislation and Animal Experimentation ... Earl Wood and Helene Cecil. 7 20014 Invitation to Membership in the NSMR. 9 SUSTAINING MEMBERS Frontiers in the Teaching of Physiology . 10 Abbott Laboratories Merrell Res. Ctr., Div. of APS Sections: How to Become Affiliated . ... 11 Burroughs Wellcome Co. Richardson-Merrell Inc. Member Contributions. 11 CIBA Geigy Corp. Pfizer, Inc. International Satellite Symposium. 12 Grass Instrument Co. Revlon Health Care Group Clearance Sale 18 Hoechst-Roussel Pharmaceu- A.H. Robins Co., Inc. Travel Awards and Application ... 19 tical Co., Inc. Sandoz, Inc. Membership Instructions and Application 21 Hoffmann-La Roche, Inc. G. D. Searle & Co. CAS Brief . 25 ICI Americas lnc. Smith Kline & French Labs. ANNOUNCEMENTS International Minerals & I.A. Squibb & Sons, Inc. Future Meetings. II Chemical Corp. The Upjohn Co. Symposium: Basic Biology of Muscles .. 5 Eli Lilly and Co. Waverly Press MIT Summer Course . 5 McNeil Laboratories Wyeth Laboratories, Inc. Fulbright Appointments 1981-83 10 Merck Sharp & Dohme Symposium on Respiratory System.
    [Show full text]
  • Balcomk41251.Pdf (558.9Kb)
    Copyright by Karen Suzanne Balcom 2005 The Dissertation Committee for Karen Suzanne Balcom Certifies that this is the approved version of the following dissertation: Discovery and Information Use Patterns of Nobel Laureates in Physiology or Medicine Committee: E. Glynn Harmon, Supervisor Julie Hallmark Billie Grace Herring James D. Legler Brooke E. Sheldon Discovery and Information Use Patterns of Nobel Laureates in Physiology or Medicine by Karen Suzanne Balcom, B.A., M.L.S. Dissertation Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy The University of Texas at Austin August, 2005 Dedication I dedicate this dissertation to my first teachers: my father, George Sheldon Balcom, who passed away before this task was begun, and to my mother, Marian Dyer Balcom, who passed away before it was completed. I also dedicate it to my dissertation committee members: Drs. Billie Grace Herring, Brooke Sheldon, Julie Hallmark and to my supervisor, Dr. Glynn Harmon. They were all teachers, mentors, and friends who lifted me up when I was down. Acknowledgements I would first like to thank my committee: Julie Hallmark, Billie Grace Herring, Jim Legler, M.D., Brooke E. Sheldon, and Glynn Harmon for their encouragement, patience and support during the nine years that this investigation was a work in progress. I could not have had a better committee. They are my enduring friends and I hope I prove worthy of the faith they have always showed in me. I am grateful to Dr.
    [Show full text]
  • Nobel Laureate Surgeons
    Literature Review World Journal of Surgery and Surgical Research Published: 12 Mar, 2020 Nobel Laureate Surgeons Jayant Radhakrishnan1* and Mohammad Ezzi1,2 1Department of Surgery and Urology, University of Illinois, USA 2Department of Surgery, Jazan University, Saudi Arabia Abstract This is a brief account of the notable contributions and some foibles of surgeons who have won the Nobel Prize for physiology or medicine since it was first awarded in 1901. Keywords: Nobel Prize in physiology or medicine; Surgical Nobel laureates; Pathology and surgery Introduction The Nobel Prize for physiology or medicine has been awarded to 219 scientists in the last 119 years. Eleven members of this illustrious group are surgeons although their awards have not always been for surgical innovations. Names of these surgeons with the year of the award and why they received it are listed below: Emil Theodor Kocher - 1909: Thyroid physiology, pathology and surgery. Alvar Gullstrand - 1911: Path of refracted light through the ocular lens. Alexis Carrel - 1912: Methods for suturing blood vessels and transplantation. Robert Barany - 1914: Function of the vestibular apparatus. Frederick Grant Banting - 1923: Extraction of insulin and treatment of diabetes. Alexander Fleming - 1945: Discovery of penicillin. Walter Rudolf Hess - 1949: Brain mapping for control of internal bodily functions. Werner Theodor Otto Forssmann - 1956: Cardiac catheterization. Charles Brenton Huggins - 1966: Hormonal control of prostate cancer. OPEN ACCESS Joseph Edward Murray - 1990: Organ transplantation. *Correspondence: Shinya Yamanaka-2012: Reprogramming of mature cells for pluripotency. Jayant Radhakrishnan, Department of Surgery and Urology, University of Emil Theodor Kocher (August 25, 1841 to July 27, 1917) Illinois, 1502, 71st, Street Darien, IL Kocher received the award in 1909 “for his work on the physiology, pathology and surgery of the 60561, Chicago, Illinois, USA, thyroid gland” [1].
    [Show full text]
  • GEORGE RICHARDS MINOT December 2, 1885-February 25, 1950
    NATIONAL ACADEMY OF SCIENCES G EORGE RICHARDS M INOT 1885—1950 A Biographical Memoir by W . B . C ASTLE Any opinions expressed in this memoir are those of the author(s) and do not necessarily reflect the views of the National Academy of Sciences. Biographical Memoir COPYRIGHT 1974 NATIONAL ACADEMY OF SCIENCES WASHINGTON D.C. i GEORGE RICHARDS MINOT December 2, 1885-February 25, 1950 BY W. B. CASTLE EORGE MINOT was born in Boston, Massachusetts, on Decem- G ber 2, 1885, the eldest of three sons of Dr. James Jackson and Elizabeth Frances (Whitney) Minot. His ancestors had been successful in business and professional careers in Boston. His father was a private practitioner and for many years a clinical teacher of medicine as a member of the staff of the Massachusetts General Hospital. In the second half of the nineteenth century his great uncle, Francis Minot, became the third Hersey Pro- fessor of the Theory and Practice of Physic at Harvard; and his cousin, Charles Sedgwick Minot, a distinguished anatomist, was Professor of Histology there in the early years of the twentieth century. George Minot's grandmother was the daughter of Dr. James Jackson, the second Hersey Professor and a cofounder with John Collins Warren of the Massachusetts General Hos- pital, which opened its doors in 1821. Thus his forebears, like those of other Boston medical families, were influential par- ticipants in the activities of the Harvard Medical School and its affiliated teaching hospital. George was regarded by his physician-father as a delicate child who required physical protection and nourishing food.
    [Show full text]
  • Alfred Nobel and His Prizes: from Dynamite to DNA
    Open Access Rambam Maimonides Medical Journal NOBEL PRIZE RETROSPECTIVE AFTER 115 YEARS Alfred Nobel and His Prizes: From Dynamite to DNA Marshall A. Lichtman, M.D.* Department of Medicine and the James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA ABSTRACT Alfred Nobel was one of the most successful chemists, inventors, entrepreneurs, and businessmen of the late nineteenth century. In a decision later in life, he rewrote his will to leave virtually all his fortune to establish prizes for persons of any nationality who made the most compelling achievement for the benefit of mankind in the fields of chemistry, physics, physiology or medicine, literature, and peace among nations. The prizes were first awarded in 1901, five years after his death. In considering his choice of prizes, it may be pertinent that he used the principles of chemistry and physics in his inventions and he had a lifelong devotion to science, he suffered and died from severe coronary and cerebral atherosclerosis, and he was a bibliophile, an author, and mingled with the literati of Paris. His interest in harmony among nations may have derived from the effects of the applications of his inventions in warfare (“merchant of death”) and his friendship with a leader in the movement to bring peace to nations of Europe. After some controversy, including Nobel’s citizenship, the mechanisms to choose the laureates and make four of the awards were developed by a foundation established in Stockholm; the choice of the laureate for promoting harmony among nations was assigned to the Norwegian Storting, another controversy.
    [Show full text]
  • Nobel Prize Commemoration in Riga: Media Echo and Objects
    Acta medico-historica Rigensia (2018) XI: 92-120 doi:10.25143/amhr.2018.XI.03 Juris Salaks, Nils Hansson Nobel Prize Commemoration in Riga: Media Echo and Objects Abstract This paper is an attempt to investigate the discourses around the Nobel Prize, and it aims at deciphering the commemoration of the award in Riga. The public image of the Nobel Prize in Riga has previously been commented on in a few papers, but has never been studied at length. The first part of the current study contextualises several Nobel links from the city, universi- ties and state printed media, as well as more hidden tracks from the Nobel Prize nominations’ archive. The second part highlights Ilya Mechnikov (Elie Metchnikoff’s, Nobel laureate in physiology or medicine in 1908) collection in Pauls Stradins Museum of the History of Medicine, including a detailed description of his Nobel medal and his ambivalent feelings about this award. Keywords: Nobel Prize, Latvian press, Riga, Baltic States, Ilya Mechnikov (Elie Metchnikoff), Paul Ehrlich, Wilhelm Ostwald, Paul Valden, Ernst von Bergmann, Harald zur Hausen. Several compendia on the history of medicine use the Nobel Prize in physiology or medicine as a lens for reviewing scientific trends in the history of medicine in the last century. The medical historian Erwin Ackerknecht, for instance, argued that the tendencies of the 20th century cutting-edge medicine are illustrated by the names of those who received the Nobel Prize. 1 1 Erwin H. Ackerknecht, A short history of medicine (New York: Johns Hopkins University Press, 1968). 92 Also, more recent textbooks, such as Ortrun Riha’s Grundwissen Geschichte, Theorie und Ethik der Medizin 2, Jacalyn Duffin’s History of Medicine: A Scandalously Short Introduction 3, Tatiana Sorokina’s History of Medicine 4 have (at least in some editions) enclosed lists of Nobel laureates to highlight prominent work throughout the 20th century.
    [Show full text]
  • Tierversuche in Der Forschung
    Senatskommission für tierexperimentelle Forschung der Deutschen Forschungsgemeinschaft Tierversuche in der Forschung Senatskommission für tierexperimentelle Forschung der Deutschen Forschungsgemeinschaft Tierversuche in der Forschung 2 Inhalt Vorwort . 4 Einführung . 6 Tierversuche: Definition und Zahlen Was ist ein Tierversuch? . 9 Wie viele Tiere werden verwendet? . 9 Wofür werden Tiere in der Forschung benötigt? . 11 Welche Tierarten werden eingesetzt? . 11 Europaweite Entwicklung . 14 Tierexperimentelle Praxis: Einsatzbereiche für Versuchstiere Grundlagenforschung. 17 Medizinische Forschung. 18 Nobelpreiswürdig: Herausragende wissenschaftliche Erkenntnisse . 20 Diagnostik . 22 Transplantationsmedizin . 25 Zell- und Gewebeersatz beim Menschen. 26 Stammzellforschung . 27 Genomforschung . 28 Neurowissenschaften . 31 Veterinärmedizinische Forschung . 33 Tierversuche in der Aus-, Fort- und Weiterbildung . 35 Die Grundannahme der Übertragbarkeit auf den Menschen. 35 3 Tierversuche und Tierschutz: Ethische Abwägungen Die Entwicklung des Tierschutzgedankens in Deutschland . 39 Ethische Aspekte von Tierversuchen und das Solidaritätsprinzip. 40 Die Übertragbarkeit aus ethisch-rechtlicher Sicht. 45 Das 3 R-Prinzip . 48 Alternativen zum Tierversuch. 51 Grenzen von Alternativmethoden. 54 Die Basler Deklaration . 56 Tierversuche in Deutschland: Vom Antrag bis zur Durchführung Europäische Regelungen für Tierversuche . 59 Tierversuche unter Genehmigungsvorbehalt . 60 Rechtliche Grundlagen . 60 Genehmigungsverfahren . 63 Durchführung von Tierversuchen
    [Show full text]
  • List of Nobel Laureates 1
    List of Nobel laureates 1 List of Nobel laureates The Nobel Prizes (Swedish: Nobelpriset, Norwegian: Nobelprisen) are awarded annually by the Royal Swedish Academy of Sciences, the Swedish Academy, the Karolinska Institute, and the Norwegian Nobel Committee to individuals and organizations who make outstanding contributions in the fields of chemistry, physics, literature, peace, and physiology or medicine.[1] They were established by the 1895 will of Alfred Nobel, which dictates that the awards should be administered by the Nobel Foundation. Another prize, the Nobel Memorial Prize in Economic Sciences, was established in 1968 by the Sveriges Riksbank, the central bank of Sweden, for contributors to the field of economics.[2] Each prize is awarded by a separate committee; the Royal Swedish Academy of Sciences awards the Prizes in Physics, Chemistry, and Economics, the Karolinska Institute awards the Prize in Physiology or Medicine, and the Norwegian Nobel Committee awards the Prize in Peace.[3] Each recipient receives a medal, a diploma and a monetary award that has varied throughout the years.[2] In 1901, the recipients of the first Nobel Prizes were given 150,782 SEK, which is equal to 7,731,004 SEK in December 2007. In 2008, the winners were awarded a prize amount of 10,000,000 SEK.[4] The awards are presented in Stockholm in an annual ceremony on December 10, the anniversary of Nobel's death.[5] As of 2011, 826 individuals and 20 organizations have been awarded a Nobel Prize, including 69 winners of the Nobel Memorial Prize in Economic Sciences.[6] Four Nobel laureates were not permitted by their governments to accept the Nobel Prize.
    [Show full text]
  • 1901-2009 NOBEL PRIZE:1901-2009 O Prêmio Nobel De Medicina Desse Ano Foi Entregue a Elizabeth Blackbur
    EDITORIAL PRÊMIO NOBEL: 1901-2009 NOBEL PRIZE:1901-2009 Rosa Lúcia Vieira Maidana, Francisco Veríssimo Veronese, Sandra Pinho Silveiro O prêmio Nobel de Medicina desse ano foi entregue a Elizabeth Blackburn, Jack Szostak e Carol Greider (Figura 1) por terem elucidado a estrutura e o processo de manutenção dos telômeros, como descrevem didaticamente Jardim et al. nesse volume da revista (1). Elizabeth Blackburn (University of California, San Francisco, EUA), Jack Szostak (Harvard Medical School, Boston, EUA) e Carol Greider (Johns Hopkins University, Baltimore, EUA) descobriram que os telômeros são sequências de DNA situados nas extremidades dos cromossomos e possuem uma estrutura que protege os cromossomos de danos como a erosão. Também de- monstraram que uma enzima específica, a telomerase (descoberta em 1984 por Elizabeth Blackburn e sua então assistente Carol Greider), está envolvida no processo de reparação dos cromossomos após a mitose celular. Como descrevem Calado e Young em revisão publicada em dezembro de 2009 no New England Journal of Medicine (2), os telômeros e a telomerase são protetores contra danos ao genoma que podem surgir de uma replicação assimétrica do DNA. Sem os telômeros, o material genético poderia ser perdido toda vez que ocorre uma divisão celular. As implicações clínicas destes processos são importantes, uma vez que alte- rações nos telômeros estão causalmente relacionadas a patologias em que ocorre mutações genéticas, como a anemia aplásica. Telômeros curtos estão associados a risco aumentado de doença cardiovascular, e mutações no gene da telomerase a condições como fibrose pulmonar e hepática e susceptibilidade a alguns tipos de câncer (ex., coloretal, esôfago, leucemia mielóide).
    [Show full text]
  • Sesion Ordinaria De La Comision De Gobierno Del Dia 26 De Junio De 2.003
    SESION ORDINARIA DE LA COMISION DE GOBIERNO DEL DIA 26 DE JUNIO DE 2.003 SEÑORES ASISTENTES En el Salón de Sesio- Presidente: nes de la Casa Consistorial D. Pedro Castro Vázquez. del Ilustrísimo Ayuntamien- to de Getafe, siendo las Miembros: diez horas y treinta minu- P.S.O.E.: tos del día veintiséis de D. Fco. David Lucas Parrón. junio del año dos mil tres, Dª.Carmen Duque Revuelta. se reunieron en sesión or- D. Fco. Santos Vázquez Rabaz. dinaria, en segunda convo- D. Fernando Tena Ramiro. catoria, previamente convo- Dª.Mónica Medina Asperilla. cados al efecto, los miem- D. David Castro Valero. bros de la Comisión de Go- D. J. Manuel Vázquez Sacristán. bierno que al margen se expresan, bajo la Presiden- I.U.: cia del Sr. Alcalde Don Dª.Laura Lizaga Contreras. Pedro Castro Vázquez, pre- D. Ignacio Sánchez Coy. sente la Interventora Doña María del Carmen Miralles Interventora: Huete y actuando como Se- Dª.Mª. Carmen Miralles Huete. cretaria Doña Concepción Muñoz Yllera. Secretaria: Dª. Concepción Muñoz Yllera. A efectos de votación se hace constar que la Co- misión de Gobierno está integrada por diez miembros, incluido el Sr. Alcalde. Abierto el acto por la Presidencia se entra a conocer de los asuntos del orden del día para esta sesión. CONTRATACION PROPOSICION DEL CONCEJAL DELEGADO DE SERVICIOS DE LA CIUDAD SOBRE AMPLIACION DEL PLAZO DE EJECUCION DE LAS OBRAS INCLUI- DAS EN EL CONVENIO DE COLABORACION SUSCRITO CON IBERDROLA DISTRIBUCION ELECTRICA S.A.U. PARA EL ENTERRAMIENTO DE CEN- TROS DE TRANSFORMACION DE ALTA TENSION A LLEVAR A CABO DU- RANTE EL AÑO 2.003, AL AMPARO DEL ACUERDO ADOPTADO POR LA COMISION DE GOBIERNO DE 6 DE FEBRERO DE 2.003.
    [Show full text]